Amir Reichman's most recent trade in Scinai Immunotherapeutics Ltd - ADR was a trade of 400,000,000 Ordinary Shares done . Disclosure was reported to the exchange on June 16, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Scinai Immunotherapeutics Ltd (ADR) | Amir Reichman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2026 | 400,000,000 | 711,637,600 (272%) | 153% | 0 | Ordinary Shares |